Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
May 22, 2025 17:32 ET | Source: Soleno Therapeutics REDWOOD CITY, Calif.,…
